Chemical formula: C₁₇H₂₆N₂O Molecular mass: 274.401 g/mol PubChem compound: 175805
Ropivacaine is a long-acting amide-type local anaesthetic with both anaesthetic and analgesic effects. At high doses ropivacaine produces surgical anaesthesia, while at lower doses it produces sensory block with limited and non-progressive motor block.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N01BB09 | Ropivacaine | N Nervous system → N01 Anesthetics → N01B Anesthetics, local → N01BB Amides |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| NAROPIN Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
| ROPIVACAINE Solution for infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Ropivacaine is an active ingredient of these brands:
United States (US)
Canada (CA)
France (FR)
Hong Kong (HK)
Ireland (IE)
Japan (JP)
Poland (PL)
Singapore (SG)
South Africa (ZA)
United Kingdom (UK)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
